Suggested links

Mesothelioma Treatment by State

It can take up to 50 years to develop mesothelioma after asbestos exposure, which means there are thousands of people across the United States being diagnosed each year who need treatment. These patients can find help from specialized doctors at top cancer centers and hospitals throughout the nation. Learn more about mesothelioma treatment by state below.

Fact-Checked and Updated by: Jenna Tozzi, RN

Last updated:

How Do I Find Mesothelioma Treatment Near Me?

If you’ve been diagnosed with mesothelioma, you and your family may be wondering where you can get the best treatment. Fortunately, there are many cancer centers across the country with doctors who specialize in mesothelioma. These doctors can develop a custom treatment plan based on your individual needs and diagnosis.

Your treatment plan may include a combination of chemotherapy, surgery, and other therapies. You may also be able to access new treatments through clinical trials.

The first step to receiving the right treatment is to make an appointment with a mesothelioma specialist.

We can help you connect with local mesothelioma doctors regardless of where you live. Try our Free Doctor Match now.

Mesothelioma doctor talking with an older couple
Free Mesothelioma Doctor Match

We'll help you connect with a local mesothelioma specialist for personalized treatment.

Find a Doctor Near You

Top States for Mesothelioma Treatment

From Moffitt Cancer Center in Tampa to UCLA Medical Center in Los Angeles, there are a number of mesothelioma treatment centers across the country that can provide patients with specialized cancer care.

Some of the best mesothelioma cancer centers are located in:

If you or a loved one is researching mesothelioma cancer centers, try looking for hospitals that have been recognized by the National Cancer Institute (NCI). This indicates that the facility has met strict criteria for conducting advanced cancer research aimed at finding better ways to prevent, diagnose, and treat mesothelioma.

All of the states listed above are home to at least one NCI-designated cancer center.

Mesothelioma Treatment Options

Pursuing treatment at a mesothelioma center is critical to improving your overall prognosis and life expectancy.

Did You Know?

Pleural mesothelioma patients who receive standard treatments have higher survival rates than patients who go untreated, according to a 2023 report published in the journal Cancer Medicine.

Standard mesothelioma treatment options include:

  • Surgery: Malignant mesothelioma patients may be eligible for tumor-removing surgeries as well as minor outpatient procedures that can help relieve swelling, chest pain, and other painful symptoms.
  • Chemotherapy: Powerful chemotherapy medications administered orally or intravenously target and kill mesothelioma cancer cells throughout the body.
  • Radiation therapy: High-energy radiation is delivered directly to areas with mesothelioma tumors, destroying cancer cells while minimizing damage to healthy tissues.

Mesothelioma cancer centers also offer emerging treatments such as immunotherapy that are being tested in clinical trials and showing improvements in overall survival for some mesothelioma patients. Immunotherapy drugs work by activating the body’s immune response to target and destroy cancer cells.

A 2021 clinical trial led by researchers at MD Anderson Cancer Center found that 40% of peritoneal mesothelioma patients achieved complete or partial remission after being treated with the immunotherapy medications atezolizumab (TECENTRIQ®) and bevacizumab (Avastin®).

Make sure to ask your specialist which treatment options are best for your stage and type of mesothelioma. Download our Free Checklist of Questions to Ask Your Doctor before your next appointment so you leave with the answers you need.

14 Questions to Ask Your Doctor packet
Free Download: 14 Questions to Ask Your Doctor
  • Preparing for treatment
  • Finding clinical trials
  • Getting a second opinion

Get Your Free Download

Locate Mesothelioma Clinical Trials Near You

Clinical trials for mesothelioma are available in some states. Mesothelioma Hope maintains an up-to-date list of ongoing clinical trials categorized by location.

Use our search tool below to see if there are any active mesothelioma clinical trials in your area and get help enrolling.

Active Mesothelioma Clinical Trials (77)Show trials only in:
Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.
Location: New York, New York
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Conditions
  • Malignant Pleural Mesothelioma
Interventions
  • Biological: Safety
Facility
  • Icahn School of Medicine Mount Sinai, New York, New York
Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
Location: Bethesda, Maryland
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Phase I Study of Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Conditions
  • Mesothelioma
Interventions
  • Biological: LMB-100
  • Drug: ipilimumab
Facility
  • National Institutes of Health Clinical Center, Bethesda, Maryland
Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
Location: Basking Ridge, New Jersey (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Feasibility and Safety of Neoadjuvant Nivolumab and Chemotherapy for Resectable Malignant Pleural Mesothelioma

Conditions
  • Malignant Pleural Mesothelioma
Interventions
  • Drug: Nivolumab
  • Drug: Pemetrexed
  • Drug: Cisplatin or Carboplatin
Facility
  • Memoiral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey
  • Memorial Sloan Kettering Commack, Commack, New York
  • Memorial Sloan Kettering Westchester, Harrison, New York
  • Memorial Sloan Kettering Cancer Center, New York, New York
  • Memorial Sloan Kettering Nassau, Uniondale, New York
Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine
Location: Philadelphia, Pennsylvania
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Conditions
  • Mesotheliomas Pleural
Interventions
  • Drug: Pembrolizumab
  • Procedure: Indocyanine Green (ICG) Image-Guided Surgery
  • Drug: Cisplatin
  • Drug: Pemetrexed
Facility
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center
Location: Houston, Texas
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Conditions
    Interventions
    • Drug: CAR.70/IL15-transduced CB-derived NK cells
    • Drug: Fludarabine phosphate
    • Drug: Cyclophosphamide
    Facility
    • M D Anderson Cancer Center, Houston, Texas
    Clinical Trial for Mesothelioma from PrECOG, LLC.
    Location: La Jolla, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from PrECOG, LLC.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

    Conditions
    • Mesothelioma
    • Pleural Mesothelioma
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: Durvalumab
    Facility
    • University of California San Diego, La Jolla, California
    • University of Miami, Miami, Florida
    • Moffitt Cancer Center, Tampa, Florida
    • Emory University, Atlanta, Georgia
    • University of Chicago, Chicago, Illinois
    • NorthShore University Health System/Kellogg Cancer Center, Evanston, Illinois
    • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
    • Massaschusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • University of Michigan, Ann Arbor, Michigan
    • Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota
    • Morristown Medical/Atlantic Health, Morristown, New Jersey
    • Jersey Shore University Medical Center, Neptune, New Jersey
    • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
    • Memorial Sloan Kettering, New York, New York
    • University of Cincinnati, Cincinnati, Ohio
    • Cleveland Clinic Foundation, Cleveland, Ohio
    • The Ohio State University, Columbus, Ohio
    • Penn State Cancer Institute, Hershey, Pennsylvania
    • Abramson Cancer Cener at Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
    • Fox Chase Cancer Center, Philadelphia, Pennsylvania
    • Allegheny Cancer Center, Pittsburgh, Pennsylvania
    • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
    • University of Texas Southwestern Medical Center, Dallas, Texas
    • Baylor College of Medicine, Houston, Texas
    • MD Anderson Cancer Center, Houston, Texas
    • University of Virginia, Charlottesville, Virginia
    Clinical Trial for Pleural Mesothelioma from University of Chicago
    Location: Chicago, Illinois
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Mesothelioma from University of Chicago

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Pilot Window-of-opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

    Conditions
    • Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Drug: Cisplatin and Pemetrexed
    Facility
    • University of Chicago, Chicago, Illinois
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC
    Location: Los Angeles, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

    Conditions
    • Small Cell Lung Carcinoma
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
    Interventions
    • Biological: pembrolizumab
    Facility
    • Call for Information (Investigational Site 0202), Los Angeles, California
    • Call for Information (Investigational Site 0017), Los Angeles, California
    • Call for Information (Investigational Site 0010), Boston, Massachusetts
    • Call for Information (Investigational Site 0008), New Brunswick, New Jersey
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.
    Location: Gilbert, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing

    Conditions
    • Non Small Cell Lung Cancer
    • Mesothelioma
    • Mesothelioma, Malignant
    • Mesothelioma; Lung
    Facility
    • Banner Health, Gilbert, Arizona
    • City of Hope, Duarte, California
    • University of California San Diego, La Jolla, California
    • Stanford University, Palo Alto, California
    • UCLA Medical Center, Santa Monica, California
    • Mayo Clinic Jacksonville, Jacksonville, Florida
    • Moffitt Cancer Center, Tampa, Florida
    • Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts
    • Mayo Clinic Rochester, Rochester, Minnesota
    • Washington University, Saint Louis, Missouri
    • NYU Langone Medical Center, New York, New York
    • MD Anderson Cancer Center, Houston, Texas
    • Fred Hutchinson Cancer Center, Seattle, Washington
    Clinical Trial for Pancreatic Cancer from Takeda
    Location: Birmingham, Alabama (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pancreatic Cancer from Takeda

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    An Open-label, Dose Escalation and Expansion, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of TAK-500, a Novel Stimulator of Interferon Genes Agonist, as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Select Locally Advanced or Metastatic Solid Tumors

    Conditions
    • Mesothelioma
    • Non-small Cell Lung Cancer (NSCLC), Non-squamous
    Interventions
    • Drug: TAK-500
    Facility
    • Univeristy of Alabama at Birmingham, Birmingham, Alabama
    • City of Hope, Duarte, California
    • University of California San Diego, La Jolla, California
    • University of Colorado - Anschutz Medical Campus - PPDS, Aurora, Colorado
    • Sarah Cannon Research Institute, Denver, Colorado
    • Sylvester Comprehensive Cancer Center, Miami, Florida
    • Northwestern, Chicago, Illinois
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Fox Chase Cancer Center, Philadelphia, Pennsylvania
    • Sarah Cannon Cancer Institute, Nashville, Tennessee
    • START South Texas Accelerated Research Therapeutics, San Antonio, Texas
    Clinical Trial for Solid Tumors from Inhibrx, Inc.
    Location: Scottsdale, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumors from Inhibrx, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: INBRX-109
    Facility
    • HonorHealth Research Institute, Scottsdale, Arizona
    • City of Hope, Duarte, California
    • Valkyrie Clinical Trials, Los Angeles, California
    • University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California
    • Sarcoma Oncology Center, Santa Monica, California
    • University of Colorado Hospital, Aurora, Colorado
    • Emory University - Winship Cancer Institute, Atlanta, Georgia
    • The University of Chicago, Chicago, Illinois
    • University of Michigan, Ann Arbor, Michigan
    • START Midwest Michigan, PC, Grand Rapids, Michigan
    • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York
    • Cleveland Clinic, Cleveland, Ohio
    • Oregon Health & Science University, Portland, Oregon
    • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania
    • Vanderbilt University School of Medicine, Nashville, Tennessee
    • UT MD Anderson Cancer Center, Houston, Texas
    • NEXT Oncology, San Antonio, Texas
    • NEXT Oncology - Virginia, Fairfax, Virginia
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase I Dose Escalation and Local Control Study of Pembrolizumab + Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Radiation: IMPRINT
    Facility
    • Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
    • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York
    • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York
    Clinical Trial for Cutaneous Melanoma from Seagen Inc.
    Location: San Francisco, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Cutaneous Melanoma from Seagen Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1 Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

    Conditions
    • Non-small Cell Lung Cancer
    • Mesothelioma
    Interventions
    • Drug: SGN-BB228
    Facility
    • University of California, San Francisco | HDFCCC - Hematopoietic Malignancies, San Francisco, California
    • Sarah Cannon Research Institute at HealthONE - Denver, Denver, Colorado
    • Northwestern University, Chicago, Illinois
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • NYU Langone Hospital, New York, New York
    • Duke University Medical Center, Durham, North Carolina
    • Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington, Seattle, Washington
    Clinical Trial for Adenocarcinoma from Taproot Health
    Location: Idaho Falls, Idaho (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Adenocarcinoma from Taproot Health

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)

    Conditions
    • Lung Cancer
    • Mesothelioma
    Interventions
    • Diagnostic Test: Biomarker Testing (L)
    • Drug: Systemic Treatment (T)
    Facility
    • Teton Cancer Institute, Idaho Falls, Idaho
    • Oncology and Hematology of South Texas, Laredo, Texas
    Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics
    Location: Ocala, Florida (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-471 Administered Either as a Monotherapy or in Combination With Pembrolizumab in Patients With Inadequate Responses to PD-1/PD-L1 Checkpoint Inhibitors in Metastatic or Locally Advanced Malignancies

    Conditions
    • Metastatic Cancer
    • Non-small Cell Lung Cancer
    • Small Cell Lung Cancer
    • Mesothelioma
    Interventions
    • Drug: CTX-471
    Facility
    • Ocala Oncology Center, Ocala, Florida
    • Hematology Oncology Associates Of The Treasure Coast, Port Saint Lucie, Florida
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Washington University School of Medicine, Siteman Cancer Center, Saint Louis, Missouri
    • Hackensack University Medical Center, Hackensack, New Jersey
    • Mt Sinai, New York, New York
    • Duke University School of Medicine, Durham, North Carolina
    • Institute for Translational Oncology Research (ITOR), Greenville, South Carolina
    • Mary Crowley Cancer Research, Dallas, Texas
    Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

    Conditions
    • Peritoneal Carcinomatosis
    • Peritoneal Mesothelioma
    Interventions
    • Procedure: Heated Intraperitonial Chemotherapy
    • Drug: Oxaliplatin
    • Drug: 5-Fluorouracil
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Mesothelioma from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Staging Procedures to Diagnose Malignant Pleural Mesothelioma

    Conditions
    • Mesothelioma
    • Solitary Fibrous Tumor of the Pleura
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Mesothelioma from TCR2 Therapeutics
    Location: San Francisco, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from TCR2 Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

    Conditions
    • Mesothelioma
    • Mesotheliomas Pleural
    • Mesothelioma, Malignant
    • Mesothelioma Peritoneum
    • Non Small Cell Lung Cancer
    Interventions
    • Biological: TC-510
    • Drug: Fludarabine
    • Drug: Cyclophosphamide
    Facility
    • University of California, San Francisco, San Francisco, California
    • University of Miami, Miami, Florida
    • National Cancer Institute, Bethesda, Maryland
    • University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota
    • Montefiore Einstein Cancer Center, Bronx, New York
    • University of Oklahoma, Oklahoma City, Oklahoma
    • Sarah Cannon Research Institute, Nashville, Tennessee
    Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center
    Location: Houston, Texas
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults

    Conditions
    • Recurrent Malignant Mesothelioma
    • Refractory Malignant Mesothelioma
    Interventions
    • Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells
    • Drug: Cyclophosphamide
    • Drug: Etoposide
    Facility
    • M D Anderson Cancer Center, Houston, Texas
    Clinical Trial for Uveal Melanoma from Ohio State University
    Location: Columbus, Ohio
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Uveal Melanoma from Ohio State University

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

    Conditions
    • BAP1 Gene Mutation
    • Mesothelioma
    Facility
    • The Ohio State University Wexner Medical Center, Columbus, Ohio
    Clinical Trial for Gastric Cancer from University of Pittsburgh
    Location: Pittsburgh, Pennsylvania
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Gastric Cancer from University of Pittsburgh

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers

    Conditions
    • Mesothelioma
    Interventions
    • Biological: Tumor Infiltrating Lymphocytes (TIL)
    • Drug: Fludarabine + Cyclophosphamide combination
    Facility
    • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
    Clinical Trial for Mesothelioma from Brigham and Women's Hospital
    Location: Boston, Massachusetts
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Brigham and Women's Hospital

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI

    Conditions
    • Mesothelioma
    Interventions
    • Drug: Magnesium sulfate
    Facility
    • Brigham and Women's Hospital, Boston, Massachusetts
    Clinical Trial for Solid Tumors, Adult from Ikena Oncology
    Location: Boston, Massachusetts (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumors, Adult from Ikena Oncology

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1, First-in-Human Study of IK-930, an Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors

    Conditions
    • Mesothelioma (MPM)
    Interventions
    • Drug: IK-930
    Facility
    • Massachusetts General Hospital, Boston, Massachusetts
    • Start Midwest, Grand Rapids, Michigan
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania
    • Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    • Sarah Cannon Research Institute, Nashville, Tennessee
    • MD Anderson Cancer Center, Houston, Texas
    • Next Oncology, San Antonio, Texas
    Clinical Trial for Mesothelioma from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Location: Baltimore, Maryland (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

    Conditions
    • Mesothelioma
    Interventions
    • Drug: Nivolumab Injection
    Facility
    • Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine, Baltimore, Maryland
    • Johns Hopkins University, Baltimore, Maryland
    • University of Texas M.D. Anderson Cancer Center, Houston, Texas
    Clinical Trial for Cancer from Aminex Therapeutics, Inc.
    Location: Phoenix, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Cancer from Aminex Therapeutics, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer

    Conditions
    • Nsclc
    • Mesotheliomas Pleural
    • Mesothelioma Peritoneum
    Interventions
    • Drug: AMXT1501
    • Drug: DFMO
    Facility
    • Mayo Clinic - Arizona, Phoenix, Arizona
    • Mayo Clinic - Florida, Jacksonville, Florida
    • Mayo Clinic - Minnesota, Rochester, Minnesota
    • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • MD Anderson Cancer Center, Houston, Texas
    • Fred Hutch Cancer Center - Seattle Cancer Care Alliance, Seattle, Washington
    Clinical Trial for Mesothelioma from TCR2 Therapeutics
    Location: San Francisco, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from TCR2 Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer

    Conditions
    • Mesothelioma
    • Mesothelioma, Malignant
    • Mesothelioma; Pleura
    • Mesotheliomas Pleural
    • Mesothelioma Peritoneum
    • Non Small Cell Lung Cancer
    • Non Small Cell Lung Cancer Metastatic
    Interventions
    • Biological: gavo-cel
    • Drug: fludarabine
    • Drug: cyclophosphamide
    Facility
    • University of California, San Francisco, San Francisco, California
    • University of Miami Sylvester Cancer Center, Miami, Florida
    • University of Chicago Medical Center, Chicago, Illinois
    • National Cancer Institute, Bethesda, Maryland
    • Columbia University Medical Center, New York, New York
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • Duke University, Durham, North Carolina
    • University of Pennsylvania, Philadelphia, Pennsylvania
    • Sarah Cannon Research Institute, Nashville, Tennessee
    • University of Texas MD Anderson Cancer Center, Houston, Texas
    Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center
    Location: New York, New York
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Single-Arm, Open-Label, Phase I Trial to Assess the Safety of Genetically Engineered Autologous T Cells Targeting the Cell Surface Antigen Mesothelin With Cell-Intrinsic Checkpoint Inhibition in Patients With Mesothelioma

    Conditions
    • Malignant Pleural Mesothelioma (MPM)
    Interventions
    • Drug: cyclophosphamide
    • Biological: CAR T cells
    Facility
    • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
    Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc
    Location: Chicago, Illinois (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase 1, Multi-Center, Open-Label, Study to Evaluate the Safety, Tolerability, and PK of VT3989 in Patients With Refractory Locally Advanced or Metastatic Solid Tumors Enriched for Tumors Harboring Mutations of the NF2 Gene

    Conditions
    • Mesothelioma
    Interventions
    • Drug: VT3989
    Facility
    • University of Chicago Medical Center, Chicago, Illinois
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • MD Anderson Cancer Center, Houston, Texas
    • NEXT Oncology, San Antonio, Texas
    Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics
    Location: Scottsdale, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1a/1b, Open-Label, Multi-Center, Dose Escalation and Expansion Study of HFB200301 (TNFR2 Agonist Antibody) as a Single Agent and in Combination With Tislelizumab (Anti-PD-1 Antibody) in Adult Patients With Advanced Solid Tumors

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: HFB200301
    Facility
    • Mayo Clinic, Scottsdale, Arizona
    • USC/Norris Comprehensive Cancer Center, Los Angeles, California
    • Mayo Clinic, Jacksonville, Florida
    • Mayo Clinic, Rochester, Minnesota
    • Washington University School of Medicine, Saint Louis, Missouri
    • The University of Texas, MD Anderson Cancer Center, Houston, Texas
    • NEXT Virginia Cancer Specialists, Fairfax, Virginia
    Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.
    Location: Phoenix, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: MRTX1719
    Facility
    • Mayo Clinic, Phoenix, Arizona
    • Sarah Cannon Research Institute at HealthONE, Denver, Colorado
    • Mayo Clinic, Jacksonville, Florida
    • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Mayo Clinic, Rochester, Minnesota
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • NorthShore Hematology Oncology Associates P.C New York Cancer and Blood Specialists, Port Jefferson Station, New York
    • Sarah Cannon Research Institute, Nashville, Tennessee
    • MD Anderson Cancer Center, Houston, Texas
    • Oncology Consultants, P.A., Houston, Texas
    • START Center for Cancer Care, San Antonio, Texas
    • NEXT Virginia, Fairfax, Virginia
    • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin
    Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.
    Location: San Francisco, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors

    Conditions
    • Non-Small Cell Lung Cancer Squamous
    • Non-Small Cell Lung Cancer Non-squamous
    • Pleural Mesothelioma
    Interventions
    • Drug: MDNA11
    • Drug: Pembrolizumab
    Facility
    • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
    • Providence Saint John's Health Center, Santa Monica, California
    • Boca Raton Regional Hospital, Boca Raton, Florida
    • Orlando Health Cancer Institute, Orlando, Florida
    • Emory - Winship Cancer Institute, Atlanta, Georgia
    • Karmanos Cancer Institute, Detroit, Michigan
    Clinical Trial for Ovarian Cancer from ProfoundBio US Co.
    Location: Los Angeles, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Ovarian Cancer from ProfoundBio US Co.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors

    Conditions
    • Primary Peritoneal Carcinoma
    • Non-small Cell Lung Cancer
    • Mesothelioma
    Interventions
    • Drug: PRO1184
    Facility
    • University of California Los Angeles Medical Center, Los Angeles, California
    • University of California, San Diego; Moores Cancer Center, San Diego, California
    • Providence Medical Foundation, Santa Rosa, California
    • University of Kansas Medical Center (KUMC), Westwood, Kansas
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Karmanos Cancer Institute, Detroit, Michigan
    • University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma
    • Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee
    • Mary Crowley Cancer Research, Dallas, Texas
    • START Mountain Region, West Valley City, Utah
    Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc
    Location: Los Angeles, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: NGM707
    Facility
    • University of Southern California, Los Angeles, California
    • Hoag Memorial Hospital Presbyterian, Newport Beach, California
    • UCLA Medical Center, Santa Monica, California
    • Georgetown University Medical Center, Washington, District of Columbia
    • Florida Cancer Specialists - Sarasota - SCRI, Sarasota, Florida
    • University of Maryland Greenebaum Cancer Center, Baltimore, Maryland
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • START Midwest, LLC, Grand Rapids, Michigan
    • Nebraska Cancer Specialists, Omaha, Nebraska
    • Prisma Health - Upstate, Greenville, South Carolina
    • University of Texas Southwestern Medical Center, Dallas, Texas
    • MD Anderson Cancer Center, Houston, Texas
    • NEXT Oncology, San Antonio, Texas
    Clinical Trial for Pleural Effusion, Malignant from Travera Inc
    Location: Oakland, California
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Effusion, Malignant from Travera Inc

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance

    Conditions
    • Pleural Effusion, Malignant
    • Ascites, Malignant
    • Mesothelioma
    Facility
    • xCures, Oakland, California
    Clinical Trial for Mesothelioma from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

    Conditions
    • Mesothelioma
    • Solitary Fibrous Tumor of the Pleura
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Pleural Mesothelial Neoplasm from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Mesothelial Neoplasm from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    SBRT With Immunotherapy for Mesothelioma

    Conditions
    • Pleural Mesothelial Neoplasm
    Interventions
    • Other: Immunotherapy
    • Other: Quality-of-Life Assessment
    • Radiation: Stereotactic Body Radiation Therapy
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Advanced Bile Duct Carcinoma from National Cancer Institute (NCI)
    Location: Sacramento, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Bile Duct Carcinoma from National Cancer Institute (NCI)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Gemcitabine in Advanced Solid Tumors With an Emphasis on Urothelial Carcinoma

    Conditions
    • Advanced Lung Non-Small Cell Carcinoma
    • Advanced Lung Small Cell Carcinoma
    • Advanced Pleural Malignant Mesothelioma
    • Stage III Lung Cancer AJCC v8
    • Stage III Pleural Malignant Mesothelioma AJCC v8
    • Stage IV Lung Cancer AJCC v8
    • Stage IV Pleural Malignant Mesothelioma AJCC v8
    Interventions
    • Drug: Cisplatin
    • Drug: Elimusertib
    Facility
    • University of California Davis Comprehensive Cancer Center, Sacramento, California
    • National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
    • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
    • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
    • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
    Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology
    Location: Kingman, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma

    Conditions
    • Pleural Biphasic Mesothelioma
    Interventions
    • Biological: Nivolumab
    • Biological: Ipilimumab
    • Procedure: Surgical Procedure
    • Procedure: Computed Tomography
    • Procedure: Magnetic Resonance Imaging
    • Procedure: Positron Emission Tomography
    Facility
    • Kingman Regional Medical Center, Kingman, Arizona
    • PCR Oncology, Arroyo Grande, California
    • Beebe South Coastal Health Campus, Frankford, Delaware
    • Beebe Medical Center, Lewes, Delaware
    • Delaware Clinical and Laboratory Physicians PA, Newark, Delaware
    • Helen F Graham Cancer Center, Newark, Delaware
    • Medical Oncology Hematology Consultants PA, Newark, Delaware
    • Christiana Care Health System-Christiana Hospital, Newark, Delaware
    • Beebe Health Campus, Rehoboth Beach, Delaware
    • Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware
    • Northwestern University, Chicago, Illinois
    • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
    • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois
    • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois
    • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois
    • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois
    • Christiana Care - Union Hospital, Elkton, Maryland
    • Carson Tahoe Regional Medical Center, Carson City, Nevada
    • Cancer and Blood Specialists-Henderson, Henderson, Nevada
    • Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada
    • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada
    • Las Vegas Cancer Center-Henderson, Henderson, Nevada
    • OptumCare Cancer Care at Seven Hills, Henderson, Nevada
    • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada
    • GenesisCare USA - Henderson, Henderson, Nevada
    • Las Vegas Urology - Green Valley, Henderson, Nevada
    • Las Vegas Urology - Pebble, Henderson, Nevada
    • Urology Specialists of Nevada - Green Valley, Henderson, Nevada
    • Las Vegas Urology - Pecos, Las Vegas, Nevada
    • OptumCare Cancer Care at Charleston, Las Vegas, Nevada
    • University Medical Center of Southern Nevada, Las Vegas, Nevada
    • Hope Cancer Care of Nevada, Las Vegas, Nevada
    • Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada
    • Urology Specialists of Nevada - Central, Las Vegas, Nevada
    • GenesisCare USA - Las Vegas, Las Vegas, Nevada
    • Sunrise Hospital and Medical Center, Las Vegas, Nevada
    • Las Vegas Prostate Cancer Center, Las Vegas, Nevada
    • Las Vegas Urology - Sunset, Las Vegas, Nevada
    • Urology Specialists of Nevada - Southwest, Las Vegas, Nevada
    • Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada
    • Ann M Wierman MD LTD, Las Vegas, Nevada
    • Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada
    • GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada
    • Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada
    • Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada
    • OptumCare Cancer Care at MountainView, Las Vegas, Nevada
    • Urology Specialists of Nevada - Northwest, Las Vegas, Nevada
    • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
    • Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada
    • Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada
    • Summerlin Hospital Medical Center, Las Vegas, Nevada
    • Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada
    • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
    • GenesisCare USA - Fort Apache, Las Vegas, Nevada
    • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada
    • Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada
    • University Cancer Center, Las Vegas, Nevada
    • Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada
    • Renown Regional Medical Center, Reno, Nevada
    • Saint Mary's Regional Medical Center, Reno, Nevada
    • Radiation Oncology Associates, Reno, Nevada
    • Duke University Medical Center, Durham, North Carolina
    • Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania
    • Overlake Medical Center, Bellevue, Washington
    • Valley Medical Center, Renton, Washington
    • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington
    Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center
    Location: Houston, Texas
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma

    Conditions
    • Malignant Mesothelioma
    Interventions
    • Drug: Brentuximab Vedotin
    • Other: Laboratory Biomarker Analysis
    Facility
    • M D Anderson Cancer Center, Houston, Texas
    Clinical Trial for Malignant Pleural Mesotheliomas (Mpm) from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesotheliomas (Mpm) from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

    Conditions
      Interventions
      • Procedure: Cytoreductive surgery
      • Drug: LMB-100
      • Diagnostic Test: Immunohistochemical Assay for Mesothelin
      Facility
      • National Institutes of Health Clinical Center, Bethesda, Maryland
      Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.
      Location: Boston, Massachusetts (multiple locations)
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

      Conditions
        Interventions
        • Drug: TNG462
        Facility
        • Dana Farber Cancer Institute, Boston, Massachusetts
        • New York University Langone Health, New York, New York
        • Sarah Cannon Tennessee Oncology, Nashville, Tennessee
        • The University of Texas MD Anderson Cancer Center, Houston, Texas
        • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
        Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.
        Location: Baltimore, Maryland
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma

        Conditions
        • Non Small Cell Lung Cancer
        • Mesothelioma
        Interventions
        • Drug: AG-01 Compound
        Facility
        • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
        Clinical Trial for Non Small Cell Lung Cancer from Molecular Templates, Inc.
        Location: Los Angeles, California (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Non Small Cell Lung Cancer from Molecular Templates, Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase 1 Open-label, Multicenter, Dose-ranging Study to Investigate Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

        Conditions
        • Non Small Cell Lung Cancer
        • Mesothelioma
        Interventions
        • Drug: MT-8421
        Facility
        • The Angeles Clinic, Los Angeles, California
        • Horizon Oncology Research, LLC, Lafayette, Indiana
        • Washington University in St. Louis, Saint Louis, Missouri
        • Weill Cornell Medicine, New York, New York
        • NEXT Oncology, Fairfax, Virginia
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

        Conditions
        • Mesothelioma
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine
        Location: Buffalo, New York (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma

        Conditions
        • Epitheliod Malignant Pleural Mesothelioma
        Interventions
        • Radiation: Photodynamic Therapy
        • Procedure: Radical Pleurectomy
        • Radiation: Chemotherapy
        • Drug: Photofrin 2.0 mg/kg
        Facility
        • Rosewell Park, Buffalo, New York
        • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
        Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute
        Location: Buffalo, New York
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Utilizing Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) With Pleural Disease or Malignant Pleural Mesothelioma (MPM) - Phase I Study

        Conditions
        • Pleural Disorder
        Interventions
        • Drug: Porfimer Sodium
        • Procedure: Video-Assisted Thoracic Surgery
        • Drug: Photodynamic Therapy
        • Device: Intraoperative PDT
        Facility
        • Roswell Park Cancer Institute, Buffalo, New York
        Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis
        Location: Boston, Massachusetts (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Tislelizumab in Patients With Select Advanced Cancers

        Conditions
        • Mesothelioma
        Interventions
        • Drug: KFA115
        Facility
        • Massachusetts General Hospital ., Boston, Massachusetts
        • NYU School of Medicine Langone Health, New York, New York
        • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
        Clinical Trial for Mesothelioma from Novartis
        Location: Chicago, Illinois (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from Novartis

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors

        Conditions
        • Mesothelioma
        Interventions
        • Drug: IAG933
        Facility
        • University of Chicago Medical Center, Chicago, Illinois
        • Massachusetts General Hospital Massachusetts General Hospital, Boston, Massachusetts
        • Cleveland Clinic Foundation, Cleveland, Ohio
        • MD Anderson Cancer Center, Houston, Texas
        Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Inpatient Hospice With Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated With an Adoptive Cellular Therapy

        Conditions
        • Mesothelioma
        • Lung Cancers
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics
        Location: Duarte, California (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed or Refractory Solid Tumors

        Conditions
        • Malignant Pleural Mesothelioma
        Interventions
        • Biological: CTX131
        Facility
        • Research Site 3, Duarte, California
        • Research Site 2, Saint Louis, Missouri
        • Research Site 4, Durham, North Carolina
        • Research Site 1, Nashville, Tennessee
        • Research Site 5, Houston, Texas
        Clinical Trial for Breast Cancer from Prelude Therapeutics
        Location: New Haven, Connecticut (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Breast Cancer from Prelude Therapeutics

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

        Conditions
        • Malignant Mesothelioma
        • Non-small Cell Lung Cancers
        Interventions
        • Drug: PRT3645
        Facility
        • Smilow Cancer Hospital Phase 1 Unit, New Haven, Connecticut
        • AdventHealth Medical Group Oncology Research at Celebration, Celebration, Florida
        • Miami Cancer Institute, Miami, Florida
        • Florida Cancer Specialists, Sarasota, Florida
        • Winship Cancer Institute, Emory University, Atlanta, Georgia
        • Laura and Isaac Perlmutter Cancer Center/ NYU Langone Health, New York, New York
        • Cleveland Clinic, Cleveland, Ohio
        • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
        • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania
        • Tennessee Oncology, PLLC, Nashville, Tennessee
        • South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
        • NEXT Virginia, Fairfax, Virginia
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
        Location: Bethesda, Maryland
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers

        Conditions
        • Mesothelioma
        Facility
        • National Institutes of Health Clinical Center, Bethesda, Maryland
        Clinical Trial for Peritoneal Metastases from Lumicell, Inc.
        Location: Boston, Massachusetts
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Peritoneal Metastases from Lumicell, Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Feasibility of the LUM Imaging System for Detection of Peritoneal Surface Malignancies

        Conditions
        • Peritoneal Metastases
        Interventions
        • Combination Product: LUM Imaging System
        Facility
        • Massachusetts General Hospital, Boston, Massachusetts
        Clinical Trial for Mesothelioma from University of Chicago
        Location: Chicago, Illinois
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from University of Chicago

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma

        Conditions
        • Mesothelioma
        Interventions
        • Drug: Olaparib
        Facility
        • University of Chicago Medical Center, Chicago, Illinois
        Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute
        Location: Boston, Massachusetts
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

        Conditions
        • Mesothelioma
        Interventions
        • Other: MPT Test
        • Other: CLDN15/VIM Test
        Facility
        • Brigham and Women's Hospital, Boston, Massachusetts
        Clinical Trial for Ovarian Cancer from Verismo Therapeutics
        Location: Philadelphia, Pennsylvania
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Ovarian Cancer from Verismo Therapeutics

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase 1 Study of SynKIR-110, Autologous T Cells Transduced With Mesothelin KIR-CAR, in Subjects With Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma

        Conditions
        • Mesothelioma, Malignant
        Interventions
        • Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
        Facility
        • University of Pennsylvania, Philadelphia, Pennsylvania
        Clinical Trial for Solid Tumor from IDEAYA Biosciences
        Location: Scottsdale, Arizona (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Solid Tumor from IDEAYA Biosciences

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors

        Conditions
          Interventions
          • Drug: IDE397
          Facility
          • Honor Health Research Institute, Scottsdale, Arizona
          • City of Hope, Duarte, California
          • Indiana University Health Hospital, Indianapolis, Indiana
          • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
          • Dana Farber Cancer Institute, Boston, Massachusetts
          • Columbia University Medical Center - Herbert Irving Pavilion, New York, New York
          • Weill Cornell Medical College, New York, New York
          • Stephenson Cancer Center, Oklahoma City, Oklahoma
          • The Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee
          • MD Anderson, Houston, Texas
          • Next Oncology, San Antonio, Texas
          Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc
          Location: New Haven, Connecticut (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase 1/1b Dose Escalation/Expansion Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

          Conditions
          • Non Small Cell Lung Cancer
          • Mesothelioma
          Interventions
          • Drug: NGM438
          Facility
          • Yale Cancer Center, New Haven, Connecticut
          • Henry Ford Health System, Detroit, Michigan
          • START Midwest, Grand Rapids, Michigan
          • Mount Sinai Hospital, New York, New York
          • MD Anderson, Houston, Texas
          Clinical Trial for Any Solid Tumors Progressed After a Prior Immunotherapy from VM Oncology, LLC
          Location: Duarte, California (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Any Solid Tumors Progressed After a Prior Immunotherapy from VM Oncology, LLC

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma

          Conditions
          • Mesothelioma
          Interventions
          • Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
          Facility
          • City of Hope National Medical Center, Duarte, California
          • Memorial Cancer Institute at Memorial Healthcare Systems, Pembroke Pines, Florida
          • Atlantic Health System, Morristown Medical Center, Morristown, New Jersey
          • Weill Cornell Medicine, Cornell University, New York, New York
          • Gabrail Cancer Center Research, Canton, Ohio
          • Erlanger Health System (Hospital); University of Tennessee College of Medicine, Chattanooga, Chattanooga, Tennessee
          • The University of Texas MD Anderson Cancer Center, Houston, Texas
          • Medical College of Wisconsin, Milwaukee, Wisconsin
          Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic
          Location: Rochester, Minnesota
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)

          Conditions
          • Recurrent Malignant Mesothelioma
          • Recurrent Primary Peritoneal Carcinoma
          • Refractory Malignant Mesothelioma
          • Resectable Malignant Mesothelioma
          • Resectable Sarcoma
          Interventions
          • Drug: Cisplatin
          • Procedure: Cytoreductive Surgery
          • Drug: Doxorubicin
          • Drug: Hyperthermic Intraperitoneal Chemotherapy
          • Drug: Sodium Thiosulfate
          Facility
          • Mayo Clinic in Rochester, Rochester, Minnesota
          Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.
          Location: Boston, Massachusetts (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG908 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

          Conditions
            Interventions
            • Drug: TNG908
            Facility
            • Massachusetts General Hospital, Boston, Massachusetts
            • Dana Farber Cancer Institute, Boston, Massachusetts
            • Washington University, Saint Louis, Missouri
            • Memorial Sloan Kettering Cancer Center, New York, New York
            • Sarah Cannon Tennessee Oncology, Nashville, Tennessee
            • The University of Texas MD Anderson Cancer Center, Houston, Texas
            • NEXT Oncology, Fairfax, Virginia
            Clinical Trial for Solid Tumors With PTCH1 Loss-of-function Mutations from Endeavor Biomedicines, Inc.
            Location: Los Angeles, California (multiple locations)
            Call (866) 608-8933 to get help enrolling in this clinical trial
            Clinical Trial for Solid Tumors With PTCH1 Loss-of-function Mutations from Endeavor Biomedicines, Inc.

            Our Patient Advocates can help you connect with clinical trials

            Call (866) 608-8933 to get started

            Trial Name
            A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

            Conditions
              Interventions
              • Drug: ENV-101 (taladegib)
              Facility
              • Research Site, Los Angeles, California
              • Research Site, San Diego, California
              • Research Site, Santa Rosa, California
              • Research Site, Tampa, Florida
              • Research Site, Zion, Illinois
              • Research Site, Covington, Louisiana
              • Research Site, Las Vegas, Nevada
              • Research Site, New York, New York
              • Research Site, Durham, North Carolina
              • Research Site, Cincinnati, Ohio
              • Research Site, Cleveland, Ohio
              • Research Site, Columbus, Ohio
              • Research Site, Pittsburgh, Pennsylvania
              • Research Site, Nashville, Tennessee
              • Research Site, Houston, Texas
              • Research Site, Fredericksburg, Virginia
              • Research Site, Lynchburg, Virginia
              • Research Site, Madison, Wisconsin
              Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)
              Location: Phoenix, Arizona (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

              Conditions
              • Peritoneal Malignant Mesothelioma
              Interventions
              • Biological: Atezolizumab
              • Biological: Bevacizumab
              • Procedure: Biospecimen Collection
              • Drug: Carboplatin
              • Procedure: Computed Tomography
              • Procedure: Cytoreductive Surgery
              • Drug: Hyperthermic Intraperitoneal Chemotherapy
              • Drug: Pemetrexed
              • Procedure: Positron Emission Tomography
              Facility
              • Mayo Clinic Hospital in Arizona, Phoenix, Arizona
              • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
              • Carle at The Riverfront, Danville, Illinois
              • Carle Physician Group-Effingham, Effingham, Illinois
              • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
              • Carle Cancer Center, Urbana, Illinois
              • The Carle Foundation Hospital, Urbana, Illinois
              • University of Kentucky/Markey Cancer Center, Lexington, Kentucky
              • Alliance for Clinical Trials in Oncology, Boston, Massachusetts
              • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
              • Fairview Southdale Hospital, Edina, Minnesota
              • Unity Hospital, Fridley, Minnesota
              • Abbott-Northwestern Hospital, Minneapolis, Minnesota
              • Mayo Clinic in Rochester, Rochester, Minnesota
              • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota
              • Regions Hospital, Saint Paul, Minnesota
              • United Hospital, Saint Paul, Minnesota
              • Sanford Bismarck Medical Center, Bismarck, North Dakota
              • Sanford Broadway Medical Center, Fargo, North Dakota
              • Sanford Roger Maris Cancer Center, Fargo, North Dakota
              • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
              • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
              • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
              • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
              • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
              • MD Anderson in The Woodlands, Conroe, Texas
              • M D Anderson Cancer Center, Houston, Texas
              • MD Anderson West Houston, Houston, Texas
              • MD Anderson League City, League City, Texas
              • MD Anderson in Sugar Land, Sugar Land, Texas
              • ThedaCare Regional Cancer Center, Appleton, Wisconsin
              • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin
              • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
              • Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin
              • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin
              • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin
              • Marshfield Medical Center - Weston, Weston, Wisconsin
              Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.
              Location: Springdale, Arkansas
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              A Phase I Study of Safety, Pharmacokinetic and Efficacy of Orally Administered APG-5918 in Patients With Advanced Solid Tumors or Hematologic Malignancies

              Conditions
              • Mesothelioma
              Interventions
              • Drug: APG-5918
              Facility
              • Highlands Oncology, Springdale, Arkansas
              Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)
              Location: Bethesda, Maryland
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

              Conditions
              • Mesothelioma
              Facility
              • National Institutes of Health Clinical Center, Bethesda, Maryland
              Clinical Trial for Microsatellite High Cancers from M.D. Anderson Cancer Center
              Location: Houston, Texas
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Microsatellite High Cancers from M.D. Anderson Cancer Center

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

              Conditions
              • Peritoneal Mesothelioma
              • Pleural Mesothelioma
              • Small Cell Lung Cancer
              Interventions
              • Drug: XmAb20717
              Facility
              • M D Anderson Cancer Center, Houston, Texas
              Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center
              Location: Chicago, Illinois (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma

              Conditions
              • Peritoneal Mesothelioma
              • Mesothelioma
              • Mesothelioma, Malignant
              • Malignant Mesothelioma
              Interventions
              • Drug: Pemetrexed
              • Drug: Cisplatin
              • Drug: Carboplatin
              Facility
              • University of Chicago (Data Collection Only), Chicago, Illinois
              • University of Nebraska (Data collection only), Omaha, Nebraska
              • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
              • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
              • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
              • Rutgers University (Data Collection Only), New Brunswick, New Jersey
              • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York
              • Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison, New York
              • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
              • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York
              • Allegheny Health Network (Data Collection Only), Pittsburgh, Pennsylvania
              Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)
              Location: Bethesda, Maryland
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

              Conditions
              • Malignant Pleural Mesotheliomas NOS
              • Lung Cancer NOS
              • Thoracic Cancers
              Facility
              • National Institutes of Health Clinical Center, Bethesda, Maryland
              Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals
              Location: Atlanta, Georgia (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              A Phase 1/2 Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

              Conditions
              • Mesothelioma, Malignant
              Interventions
              • Drug: CPI-0209
              Facility
              • Winship Cancer Institute of Emory University, Atlanta, Georgia
              • University of Chicago Medical Center, Chicago, Illinois
              • University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland
              • Massachusetts General Hospital, Boston, Massachusetts
              • Dana Farber Cancer Institute, Boston, Massachusetts
              • University of Michigan Hospital, Ann Arbor, Michigan
              • South Texas Accelerated Research Therapeutics (Start) - Midwest Location, Grand Rapids, Michigan
              • Hackensack University Medical Center, Hackensack, New Jersey
              • Montefiore Einstein Center for Cancer Care, Bronx, New York
              • NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center, New York, New York
              • Weill Medical College of Cornell University, New York, New York
              • University of Cincinnati Medical Center, Cincinnati, Ohio
              • South Texas Accelerated Research Therapeutics, San Antonio, Texas
              • University of Virginia Health System, Charlottesville, Virginia
              • Swedish Cancer Institute, Seattle, Washington
              • Fred Hutchinson Cancer, Seattle, Washington
              Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc
              Location: Gilbert, Arizona (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              A Phase 1/1b Dose Escalation/Expansion Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

              Conditions
              • Non-small Cell Lung Cancer
              • Mesothelioma
              Interventions
              • Drug: NGM831
              Facility
              • NGM Clinical Study Site, Gilbert, Arizona
              • NGM Clinical Study Site, Los Angeles, California
              • NGM Clinical Study Site, Sarasota, Florida
              • NGM Clinical Study Site, Tampa, Florida
              • NGM Clinical Study Site, Grand Rapids, Michigan
              • NGM Clinical Study Site, New York, New York
              • NGM Clinical Study Site, Oklahoma City, Oklahoma
              • NGM Clinical Study Site, Austin, Texas
              • NGM Clinical Study Site, Houston, Texas
              Clinical Trial for Mesothelioma from Mayo Clinic
              Location: Rochester, Minnesota
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Mesothelioma from Mayo Clinic

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

              Conditions
              • Mesothelioma
              • Solitary Fibrous Tumor of the Pleura
              Facility
              • Mayo Clinic in Rochester, Rochester, Minnesota
              Clinical Trial for Pancreatic Cancer from University of Nebraska
              Location: Colorado Springs, Colorado (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Pancreatic Cancer from University of Nebraska

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              Integrated Cancer Repository for Cancer Research

              Conditions
              • Lung Cancer
              • Peritoneal Surface Malignancies
              • Mesothelioma
              Facility
              • Penrose Cancer Center, Colorado Springs, Colorado
              • Porter Adventist Hospital, Denver, Colorado
              • Mercy Regional Medical Center, Durango, Colorado
              • St. Anthony Hospital, Lakewood, Colorado
              • Littleton Cancer Center, Littleton, Colorado
              • Longmont Cancer Center, Longmont, Colorado
              • Avista Cancer Center, Louisville, Colorado
              • Parker Adventist Hospital, Parker, Colorado
              • St. Mary Corwin Medical Center, Pueblo, Colorado
              • St. Anthony North Cancer Center, Westminster, Colorado
              • Florida Hospital Memorial Medical Center, Daytona Beach, Florida
              • Florida Hospital DeLand, DeLand, Florida
              • Florida Hospital FISH, Orange City, Florida
              • Florida Hospital Flagler, Palm Coast, Florida
              • Tallahassee Memorial Hospital, Tallahassee, Florida
              • Rush-Copley Cancer Care Center, Aurora, Illinois
              • Trinity Medical Center, Moline, Illinois
              • Rush-Copley Healthcare Center, Yorkville, Illinois
              • Parkview Research Center, Fort Wayne, Indiana
              • Community Health Network, Indianapolis, Indiana
              • Community Cancer Center South, Indianapolis, Indiana
              • Community Cancer Center North, Indianapolis, Indiana
              • Community Howard Regional Hospital, Kokomo, Indiana
              • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa
              • Genesis Medical Center, Davenport, Iowa
              • Abben Cancer Center, Spencer, Iowa
              • Covenant Medical Center, Inc, Waterloo, Iowa
              • Saint Luke's Cancer Instititue - South, Overland Park, Kansas
              • Tulane University, New Orleans, Louisiana
              • Breast Care Specialists of Maine, Portland, Maine
              • Northwest Hospital, Randallstown, Maryland
              • William E Kahlert Regional Cancer Center, Westminster, Maryland
              • Holyoke Medical Center, Holyoke, Massachusetts
              • University of Michigan Health System, Ann Arbor, Michigan
              • Riverwood Healthcare Center, Aitkin, Minnesota
              • Essentia Health-St. Joseph's Medical Center, Brainerd, Minnesota
              • Essentia Health - Duluth Clinic, Duluth, Minnesota
              • St. Luke's Hospital of Duluth, Duluth, Minnesota
              • Lake Region Healthcare, Fergus Falls, Minnesota
              • Avera Cancer Institute- Marshall, Marshall, Minnesota
              • Mercy Hospital - Joplin, Joplin, Missouri
              • Saint Luke's Cancer Institute, East, Kansas City, Missouri
              • Saint Luke's Cancer Institute, Kansas City, Missouri
              • Saint Luke's Cancer Institute, Kansas City North, Kansas City, Missouri
              • Saint Luke's Cancer Institute, Liberty, Liberty, Missouri
              • Heartland Regional Medical Center dba Mosaic Life Care, Saint Joseph, Missouri
              • Bozeman Health Deaconess Hospital, Bozeman, Montana
              • Logan Health, Kalispell, Montana
              • Providence St. Patrick Hospital Montana Cancer Center, Missoula, Montana
              • Mary Lanning Healthcare, Morrison Cancer Center, Hastings, Nebraska
              • Faith Regional Health Services, Carson Cancer Center, Norfolk, Nebraska
              • Great Plains Regional Medical Center, North Platte, Nebraska
              • Avera St. Anthony's Hospital, O'Neill, Nebraska
              • Methodist Estabrook Cancer Center, Omaha, Nebraska
              • Nebraska Methodist Health System, Omaha, Nebraska
              • University of Nebraska Medical Center, Omaha, Nebraska
              • Regional West Health Services, Scottsbluff, Nebraska
              • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls, New York
              • Faxton St. Luke's Healthcare, Mohawk Valley, Utica, New York
              • Cape Fear Valley Health System, Fayetteville, North Carolina
              • Essentia Health, Fargo, North Dakota
              • Trinity Hospital Cancer Care Center, Minot, North Dakota
              • Aultman Alliance Community Hospital, Alliance, Ohio
              • Aultman Hospital, Canton, Ohio
              • University of Pittsburgh, Pittsburgh, Pennsylvania
              • Avera Medical Group Oncology and Hematology Aberdeen, Aberdeen, South Dakota
              • Avera Cancer Institute, Mitchell, South Dakota
              • Avera Cancer Institute, Sioux Falls, South Dakota
              • Sanford Health, Sioux Falls, South Dakota
              • Avera Cancer Center Yankton, Yankton, South Dakota
              • Avera Sacred Heart Hospital, Yankton, South Dakota
              • Yankton Medical Clinic, Yankton, South Dakota
              • Rutland Regional Medical Center, Rutland, Vermont
              • Mary Washington Hospital, Fredericksburg, Virginia
              • Ascension St. Elizabeth Hospital, Appleton, Wisconsin
              • Wheaton Franciscan Healthcare - Elmbrook Memorial Hospital, Brookfield, Wisconsin
              • Wheaton Franciscan Healthcare, Reiman Cancer Care, Franklin, Wisconsin
              • Bellin Memorial Hospital, Green Bay, Wisconsin
              • Columbia St. Mary's, Mequon, Wisconsin
              • Columbia St. Mary's, Milwaukee, Wisconsin
              • Ascension Mercy Hospital, Oshkosh, Wisconsin
              • Wheaton Franciscan Healthcare, All Saints, Racine, Wisconsin
              • Wheaton Franciscan Healthcare, Wauwatosa Cancer Care, Wauwatosa, Wisconsin
              Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.
              Location: Los Angeles, California (multiple locations)
              Call (866) 608-8933 to get help enrolling in this clinical trial
              Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.

              Our Patient Advocates can help you connect with clinical trials

              Call (866) 608-8933 to get started

              Trial Name
              A Phase 1 Study of KZR-261, a Small Molecule Sec61 Inhibitor, in Subjects With Advanced Solid Malignancies

              Conditions
                Interventions
                • Drug: KZR-261
                Facility
                • Cedars Sinai Medical Center, Los Angeles, California
                • University of California Los Angeles, Los Angeles, California
                • Moffitt Cancer Center, Tampa, Florida
                • Winship Cancer Institute of Emory University, Atlanta, Georgia
                • Fox Chase Cancer Center, Philadelphia, Pennsylvania
                • Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville, Nashville, Tennessee
                • START (South Texas Accelerated Research Therapeutics), San Antonio, Texas
                • Virginia Cancer Specialists (VCS), Fairfax, Virginia
                Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.
                Location: Duarte, California (multiple locations)
                Call (866) 608-8933 to get help enrolling in this clinical trial
                Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.

                Our Patient Advocates can help you connect with clinical trials

                Call (866) 608-8933 to get started

                Trial Name
                A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types

                Conditions
                • Malignant Pleural Mesothelioma (MPM)
                Interventions
                • Drug: NX-1607
                Facility
                • City of Hope, Duarte, California
                • University of Southern California, Los Angeles, California
                • University of California, San Francisco, San Francisco, California
                • Memorial Sloan Kettering Cancer Center, New York, New York
                • University of North Carolina, Chapel Hill, North Carolina
                • MD Anderson Cancer Center, Houston, Texas
                • University of Virginia, Charlottesville, Virginia
                • Fred Hutchinson Cancer Center, Seattle, Washington
                Clinical Trial for Advanced Solid Tumors from PharmaMar
                Location: Boston, Massachusetts (multiple locations)
                Call (866) 608-8933 to get help enrolling in this clinical trial
                Clinical Trial for Advanced Solid Tumors from PharmaMar

                Our Patient Advocates can help you connect with clinical trials

                Call (866) 608-8933 to get started

                Trial Name
                Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors

                Conditions
                • Soft Tissue Sarcoma (Excluding GIST)
                • Mesothelioma
                Interventions
                • Drug: Lurbinectedin
                • Drug: Irinotecan
                Facility
                • Massachusetts General Hospital -, Boston, Massachusetts
                • Beth Israel Deaconess Medical Center, Boston, Massachusetts
                • The University of Texas MD Anderson Cancer Center, Houston, Texas
                Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
                Location: Basking Ridge, New Jersey (multiple locations)
                Call (866) 608-8933 to get help enrolling in this clinical trial
                Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

                Our Patient Advocates can help you connect with clinical trials

                Call (866) 608-8933 to get started

                Trial Name
                Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates

                Conditions
                • Malignant Pleural Mesothelioma
                Interventions
                • Diagnostic Test: E-Nose testing
                • Diagnostic Test: Research blood
                Facility
                • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey
                • Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey
                • Memorial Sloan Kettering Bergen (Consent Only ), Montvale, New Jersey
                • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack, New York
                • Memorial Sloan Kettering Westchester (Consent Only), Harrison, New York
                • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
                • Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York
                Clinical Trial for Advanced Solid Tumor from Incyte Corporation
                Location: Boston, Massachusetts (multiple locations)
                Call (866) 608-8933 to get help enrolling in this clinical trial
                Clinical Trial for Advanced Solid Tumor from Incyte Corporation

                Our Patient Advocates can help you connect with clinical trials

                Call (866) 608-8933 to get started

                Trial Name
                A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors

                Conditions
                • Small-cell Lung Cancer
                • Mesothelioma
                Interventions
                • Drug: INCB099280
                Facility
                • Dana Farber Cancer Institute, Boston, Massachusetts
                • Henry Ford Hospital, Detroit, Michigan
                • Upmc Cancercenter, Pittsburgh, Pennsylvania
                • Md Anderson Cancer Center, Houston, Texas
                • University of Washington, Seattle, Washington
                of Don't see what you're looking for? Call (866) 608-8933 so one of our Patient Advocates can help you find the right clinical trial.

                What State Has the Most Mesothelioma Cases?

                California ranks first among states with the most mesothelioma cases. A total of 6,503 Californians were diagnosed with mesothelioma between 1999 and 2018, according to the Centers for Disease Control and Prevention (CDC).

                Mesothelioma Rates by State

                Some states have higher rates of mesothelioma because they have a long history of industries that heavily relied on asbestos, such as shipbuilding, mining, and manufacturing.

                According to CDC data, these 10 states have the highest incidence rates for mesothelioma:

                StateMesothelioma CasesPopulationIncidence Rate
                1. Maine51326,350,6901.5%
                2. Alaska12813,839,0161.4%
                3. New Jersey2,654174,234,0481.4%
                4. Delaware27217,554,4991.4%
                5. Washington1,799132,284,0231.3%
                6. Louisiana1,22890,660,6761.3%
                7. West Virginia61436,590,1721.3%
                8. Wyoming14710,870,0111.3%
                9. Pennsylvania4,040251,711,6171.3%
                10. Wisconsin1,581112,331,9091.3%

                Thankfully, there are experienced specialists in each of these states who can treat people diagnosed with mesothelioma and other asbestos-related diseases.

                Learn more about treatments, specialists, and help for asbestos exposure in our Free Mesothelioma Guide — shipped overnight to your door.

                Mesothelioma Guide Images
                Get Your Free 2023 Mesothelioma Guide
                • Symptoms & staging
                • Average prognosis
                • Life-extending treatments

                Get Your Free Guide

                Find Mesothelioma Treatment Near You Today

                Locating mesothelioma treatment near you is a crucial step you can take toward fighting this rare cancer. With advancements in mesothelioma research and treatment options, there is increasing hope for better survival outcomes and improved quality of life.

                Our highly trained Patient Advocates can help you connect with mesothelioma doctors and treatment centers in your state. We can also see if you qualify for financial assistance that can help pay for your cancer treatments.

                Find a mesothelioma specialist in your state to get started.

                Written by:

                Director of Patient Advocacy

                Jenna Tozzi, RN, is the Director of Patient Advocacy at Mesothelioma Hope. With more than 15 years of experience as an adult and pediatric oncology nurse navigator, Jenna provides exceptional guidance and support to mesothelioma patients and their loved ones. Jenna has been featured in Oncology Nursing News and is a member of the Academy of Oncology Nurse & Patient Navigators & the American Nurses Association.

                Our Promise to You
                Our Promise to You
                References
                1. American Cancer Society. (2018, November 16). Chemotherapy for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/chemotherapy.html

                2. American Cancer Society. (2018, November 16). Immunotherapy for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/immunotherapy.html

                3. American Cancer Society. (2018, November 16). Radiation for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/radiation.html

                4. American Cancer Society. (2018, November 16). Surgery for malignant mesothelioma. Retrieved May 10, 2023, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/surgery.html

                5. American Cancer Society. (2019, May 18). What’s New in Malignant Mesothelioma Research? Retrieved May 10, 2023, from https://www.cancer.org/cancer/malignant-mesothelioma/about/new-research.html

                6. Bou-Samra, P., et al. (2023). Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database. Cancer Medicine. Retrieved May 10, 2023, from https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5915

                7. Cancer Therapy Advisor. (2017). Pleural plaques/Mesothelioma. Retrieved May 10, 2023, from https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hospital-medicine/pleural-plaques-mesothelioma/

                8. Centers for Disease Control and Prevention. (2023). United States and Puerto Rico Cancer Statistics, 1999-2018 Incidence Archive Request. Retrieved May 10, 2023, from https://wonder.cdc.gov/controller/datarequest/D172;jsessionid=DA3FC143B54F55C2AAA615EBC193?stage=results&action=sort&direction=MEASURE_DESCEND&measure=D172.M1

                9. MD Anderson Cancer Center. (2021, July 14). Atezolizumab and bevacizumab show meaningful responses for malignant peritoneal mesothelioma patients. Retrieved May 10, 2023 from https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html

                10. National Cancer Institute. (n.d.). Find a Cancer Center. Retrieved May 10, 2023, from https://www.cancer.gov/research/infrastructure/cancer-centers/find

                11. National Cancer Institute (2019, June 24). NCI-Designated Cancer Centers. Retrieved May 10, 2023, from https://www.cancer.gov/research/infrastructure/cancer-centers

                12. Rossini, M., et al. (2018). New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology. Retrieved May 10, 2023, from https://www.frontiersin.org/articles/10.3389/fonc.2018.00091/full

                Speak to a Patient Advocate About Your Options

                If you or someone you love has been diagnosed with mesothelioma, there is hope. Contact us to learn more about mesothelioma and your treatment options.

                • Latest treatment information
                • Financial assistance for treatment
                • VA benefits help

                Submit your information and a Patient Advocate will call you right back!

                Complete the Form to Speak to a Patient Advocate